دورية أكاديمية

ADAPTATION OF CHRONIC LYMPHOCYTIC LEUKEMIA TO IBRUTINIB IS MEDIATED BY EPIGENETIC PLASTICITY OF RESIDUAL DISEASE AND BY‐PASS SIGNALING VIA MAPK PATHWAY.

التفاصيل البيبلوغرافية
العنوان: ADAPTATION OF CHRONIC LYMPHOCYTIC LEUKEMIA TO IBRUTINIB IS MEDIATED BY EPIGENETIC PLASTICITY OF RESIDUAL DISEASE AND BY‐PASS SIGNALING VIA MAPK PATHWAY.
المؤلفون: Terzi di Bergamo, L, Forestieri, G, Loh, J. W, Singh, A, Spina, V, Zucchetto, A, Condoluci, A, Faderl, M, Koch, R, Bruscaggin, A, Pini, K, Wu, W, Piffaretti, D, Bittolo, T, Tissino, E, De Paoli, L, Deambrogi, C, Frustaci, A. M, Autore, F, Merli, M
المصدر: Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-2, 2p
قاعدة البيانات: Complementary Index
الوصف
تدمد:02780232
DOI:10.1002/hon.29_2879